Skip to main content

Month: September 2020

Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemission

PressmeddelandeMalmö, Sverige, 11 september 2020Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemissionAcarix AB (“Acarix” eller “Bolaget”) har avslutat den nyemission av högst 86 156 738 aktier med företrädesrätt för Bolagets befintliga aktieägare som beslutades av extra bolagsstämman den 11 augusti 2020 (“Företrädesemissionen”). Acarix offentliggör idag det slutgiltiga utfallet av Företrädesemissionen som visar, i linje med vad som kommunicerades den 9 september 2020, att Företrädesemissionen har övertecknats.Företrädesemissionen uppgick totalt till cirka 56 MSEK före avdrag för kostnader relaterade till Företrädesemissionen. Det slutgiltiga utfallet visar att 70 916 535 aktier, motsvarande cirka 82,3 procent av Företrädesemissionen, tecknades med stöd av teckningsrätter och att 35 267...

Continue reading

Pinduoduo CEO on What’s Next for Chinese E-commerce in the Wake of the Coronavirus Pandemic

Coming on the heels of a global pandemic, newly appointed Pinduoduo CEO Chen Lei discusses how the e-commerce platform plans to bring people closer to the benefits of the digital economy while staying true to the needs of a post-coronavirus marketYUNNAN, China, Sept. 11, 2020 (GLOBE NEWSWIRE) — Pinduoduo, the largest interactive e-commerce platform in China, is ready to take on the new challenge of transforming the digital economy in an era stricken by a global pandemic, according to Chief Executive Officer Chen Lei.Chen, who recently took over at the helm of the global tech giant after serving as its Chief Technology Officer, detailed where exactly the company plans to focus its pioneering efforts in technology: Agriculture. According to him, PDD will continue to explore the best use of technology to transform the industry and...

Continue reading

Ascendis Pharma A/S Announces Participation at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference

COPENHAGEN, Denmark, Sept. 11, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that the company will participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference in September. Company executives will provide a business overview and update on the company’s pipeline programs.DetailsA live webcast of the presentation will be available in the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the events for 30 days.About Ascendis Pharma A/S Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused...

Continue reading

NexTech Now Approved Microsoft Partner

VANCOUVER, British Columbia, Sept. 11, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, AR-enhanced video conferencing and virtual events is pleased to announce NexTech is now an approved Microsoft partner creating enormous new business opportunity for the company. This partnership provides access to the Azure Marketplace so that InfernoAR can be sold directly through the Marketplace.The company is also working to become part of the Microsoft cross sell program where Microsoft’s sales reps will sell InfernoAR and be incentivized to do so by the Microsoft reps getting Azure sales credits whenever they sell the InfernoAR product. Nextech is currently building new video conferencing features which will integrate...

Continue reading

Akoustis to Present at the Lake Street Best Ideas (Big4) Growth Conference on September 17, 2020

Charlotte, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that senior management will attend the 4th Annual Lake Street Best Ideas (Big4) Growth Conference which will be held virtually on September 17, 2020.Meetings will take place virtually on September 17, 2020, given the ongoing call for social distancing due to the Covid-19 pandemic. Investors that would like to schedule a meeting with Akoustis management should contact their Lake Street Capital Markets sales representative or Akoustis’ investor relations at: ir@akoustis.com.Akoustis’ high frequency, high performance XBAW process and filters are experiencing...

Continue reading

SouthCrest Bank Agrees to Strategic In Market Branch Acquisition

ATLANTA, Sept. 11, 2020 (GLOBE NEWSWIRE) — SouthCrest Financial Group (SCSG:PK), the holding company for SouthCrest Bank, N.A., announced an agreement to acquire the Thomaston branch of Colony Bank. CEO Brian D. Schmitt stated “We are extremely excited to be adding to our position as the leading bank in Thomaston and Upson County.  We look forward to giving the same great service to our new customers that we have provided in Upson County for nearly 70 years.”ABOUT SOUTHCRESTSouthCrest Financial Group, Inc. is a bank holding company with over half a billion dollars in assets, headquartered in Atlanta, GA. The company operates a 9 branch network throughout Georgia through its subsidiary bank, SouthCrest Bank, N.A. The bank provides a full suite of retail, private, entrepreneurial, high-net-worth and commercial banking services, and...

Continue reading

MPHASE SEES CONTINUED IMPROVEMENT IN KEY BUSINESS UNITS; PAYS OFF CONVERTIBLE NOTES DURING AUGUST 2020

Gaithersburg, MD, Sept. 11, 2020 (GLOBE NEWSWIRE) — mPhase Technologies, Inc. (OTCQB: XDSL) (“mPhase” or the “Company”) is providing the following update to highlight notable improvements in its travel and customer engagement divisions. The Company’s Travel Buddhi division is progressing with its white label travel solution, which provides travel agents with a turnkey portal to create and monitor their customers’ travel plans. Travel Buddhi is using a measured roll-out as it completes its technology, gaining valuable insight from initial customers. With 60 travel agent customers already onboard during the early sign-up period and new agent customers signing each week, this marks the beginning of the software as a service (SaaS) revenue cycle for Travel Buddhi. This is a major milestone in the division’s goal to develop multiple...

Continue reading

CareDx Shares Latest Clinical Data at the TTS 2020 Virtual Conference

SOUTH SAN FRANCISCO, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced that it will share the latest clinical data on its AlloSure and AlloSeq cfDNA surveillance tools at the 28th International Congress of The Transplantation Society (TTS) scheduled to be held virtually from September 13th to September 16th, 2020. The company will host four industry symposia, showcase six posters, and sponsor the plenary sessions at TTS.CareDx will host four virtual symposia on transplant care featuring the following speakers:Sunday, September 13th, 2020, 10:00 PM EDTAshraf Dada, MD, King Faisal Hospital, Jeddah – AlloSeq...

Continue reading

Editas Medicine Announces U.S. Patent and Trademark Office Grants the Broad Institute Priority Benefit in CRISPR Interference

CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, announced today the U.S. Patent and Trademark Office (USPTO) issued a decision in an interference between the University of California, the University of Vienna, Emmanuelle Charpentier (CVC) and the Broad Institute, Inc. (Broad) regarding certain Broad CRISPR/Cas9 patents Editas Medicine exclusively licenses. The USPTO granted Broad’s motion for priority benefit while denying CVC priority benefit to its two earliest provisional patent applications. As a result, Broad will enter the priority phase of the interference as “Senior Party” while CVC remains the “Junior Party” for purposes of determining which entity was the first to invent the inventions at issue.“We are pleased with the U.S. Patent and Trademark Office’s...

Continue reading

Brown & Brown, Inc. Announces the Asset Acquisition of Frank E. Neal & Co., Inc.

DAYTONA BEACH, Fla., Sept. 11, 2020 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. (NYSE:BRO), and Wink, Mark and Brent Neal, the owners of Frank E. Neal & Co., Inc., today announced that Brown & Brown of Tennessee, Inc., a subsidiary of Brown & Brown, Inc., has acquired substantially all of the assets of the Frank E. Neal & Co. Agency.For over 45 years, Frank E. Neal & Co. has provided commercial, surety, personal and employee benefits insurance solutions to entrepreneurs, established businesses and individuals throughout the Southeast region of the United States.  The agency has unique experience and deep expertise in providing surety bonds and commercial insurance solutions within the construction industry which helps fuel economic growth.  The Frank E. Neal...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.